Search

everythinglearnresearchcommunity

for

Search:↓

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

Many young women who donate blood have hormonal disorders like excess male hormones and PCOS.

DHT, a testosterone byproduct, causes male pattern baldness.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Over half of the adult women with acne in the study had higher than normal levels of male hormones, especially DHEA.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Hair loss in women not always linked to increased oil production; other factors may be involved.

Flutamide improves female hair loss when other treatments fail, but may cause liver toxicity.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

Excess male hormones in postmenopausal women can cause health issues and increase the risk of heart disease and diabetes; treatment depends on the cause.

Early diagnosis and treatment, like topical minoxidil, can prevent hair loss in children.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.

AGA patients have higher heart disease risk.

Obesity may contribute to female hair loss by increasing male hormone levels that affect hair follicles.

Vitamin D may help reduce antibody levels in men with autoimmune thyroiditis and early-onset androgenic alopecia, but has no significant impact on thyroid function.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

Excess androgens may cause PCOS, not just be a symptom.

Insulin resistance may contribute to hair loss in people with androgenic alopecia.

Female hair loss is often hereditary and can be treated with medication, hair transplants, and lasers.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.